SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex is trending due to recent high volatility and a massive intraday surge, sparking discussions about a potential short squeeze and comparisons to other recent high-flying low float stocks. The community is actively debating its potential for a multi-day run and the influence of short sellers, while also awaiting news related to acquisitions. Some traders point to a low float and high borrow rate, suggesting a possible continued upward trajectory.

SAIHEAT Ltd. engages in the operation of cryptocurrency mining. It operates Bitcoin for its own account and provides full suite of services, purchase of mining machines, hosting service, and mining pool. The company was founded by Risheng Li on February 2, 2021, and is headquartered in Singapore.

SAIHEAT Ltd. - Ordinary Shares - Class A

SAIHEAT Ltd

SAIH is trending due to community excitement around its low float and potential for a significant breakout, with many drawing comparisons to other recent parabolic runners. Discussions center on breaking key resistance levels that could trigger a rapid price increase, and its possible connection to AI and data centers.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

XCUR is trending due to positive Phase 2 data for its blood cancer treatment, sparking significant community discussion about a potential short squeeze. Traders are closely monitoring the low float stock, drawing comparisons to other high-momentum tickers and anticipating further price movement. The stock's increased trading volume and past volatility contribute to the heightened interest.

AlphaTime Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 15, 2021 and is headquartered in New York, NY.

AlphaTime Acquisition Corp

ATMC is trending due to shareholder approval of its merger with HCYC Group, driving significant after-hours volume and a potential low-float squeeze. Community discussions highlight the stock's high insider ownership and potential for continued momentum, with some comparing it to other recent low-float runners. Speculation is building around potential price targets and whether market conditions will sustain the upward trend.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

PSNY is trending due to a planned reverse stock split to maintain its NASDAQ listing, sparking mixed reactions from investors. While some see it as a potential reset and opportunity for institutional investment, others fear further dilution and compare it to other EV stocks with reverse splits. The community is actively discussing the impact of the split, potential delisting, and the company's overall financial health amidst strong revenue growth.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending as investors discuss its AI capabilities and upcoming earnings, with particular attention to its AI chip development and robotaxi service. Community members are analyzing technical indicators and debating the impact of potential stimulus measures in China. Recent analyst upgrades and positive reports on Baidu's AI initiatives have fueled optimism around the stock.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as discussions revolve around the potential of its MASH drug, Pemvidutide, following positive AI-driven analysis of trial data; the community anticipates upcoming 48-week results and a meeting with the FDA. Some are speculating about potential for accelerated approval or a buyout, while others urge caution, pointing to past data and potential dilution risks. Bullish sentiment is fueled by comparisons to other high-performing stocks in the sector.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as community members discuss recent insider buying and its potential impact on short sellers. Traders are actively monitoring share availability, cost to borrow, and dark pool activity, suggesting a possible short squeeze scenario. The stock's price movement and trading volume are also sparking conversations about potential manipulation and the overall market dynamics.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending after reporting a profitable quarter and strong revenue guidance, fueling discussions about its potential as an AI automation leader. The community is analyzing its growth prospects, comparing it to companies like $PLTR, and debating whether it could be a buyout target. Positive sentiment is building around its agentic AI capabilities and potential for significant repricing.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Fueled by interim data on their obesity drug, WVE is seeing significant volume and price appreciation. Community chatter highlights potential for a multi-day run, while some traders are wary of an upcoming offering and insider selling. The discussion revolves around the drug's prospects in the competitive weight loss market, comparing it to existing GLP-1 therapies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

https://nfne.ws/251254 $FDMIF $FDR.TSXV #exploration #FDMIF #FDR #Founders #JuniorMining #Mining #MiningStocks #Agreement #OTC #OTCMarkets

Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - Founders Metals Inc. (TSXV: FDR) (OTCQX: FDMIF) (FSE: 9DL0) ("Founders" or...